These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23881924)

  • 1. New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model.
    Raabe E; Kieran MW; Cohen KJ
    Clin Cancer Res; 2013 Sep; 19(17):4553-8. PubMed ID: 23881924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.
    Lazow MA; Hoffman L; Schafer A; Osorio DS; Boué DR; Rush S; Wright E; Lane A; DeWire-Schottmiller MD; Smolarek T; Sipple J; Taggert H; Reuss J; Salloum R; Hummel TR; de Blank P; Pillay-Smiley N; Sutton ME; Asher A; Stevenson CB; Drissi R; Finlay JL; Fouladi M; Fuller C
    Acta Neuropathol Commun; 2020 Nov; 8(1):182. PubMed ID: 33153497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF
    Ellison DW; Hawkins C; Jones DTW; Onar-Thomas A; Pfister SM; Reifenberger G; Louis DN
    Acta Neuropathol; 2019 Apr; 137(4):683-687. PubMed ID: 30848347
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma.
    Moreira DC; Qaddoumi I; Spiller S; Bouldin TW; Davidson A; Saba-Silva N; Sullivan DV; Tanaka R; Wagner AS; Wood M; Klimo P; Job G; Devidas M; Li X; Gajjar A; Robinson GW; Chiang J
    Neuro Oncol; 2024 Jul; 26(7):1327-1334. PubMed ID: 38466086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.
    Wefers AK; Stichel D; Schrimpf D; Coras R; Pages M; Tauziède-Espariat A; Varlet P; Schwarz D; Söylemezoglu F; Pohl U; Pimentel J; Meyer J; Hewer E; Japp A; Joshi A; Reuss DE; Reinhardt A; Sievers P; Casalini MB; Ebrahimi A; Huang K; Koelsche C; Low HL; Rebelo O; Marnoto D; Becker AJ; Staszewski O; Mittelbronn M; Hasselblatt M; Schittenhelm J; Cheesman E; de Oliveira RS; Queiroz RGP; Valera ET; Hans VH; Korshunov A; Olar A; Ligon KL; Pfister SM; Jaunmuktane Z; Brandner S; Tatevossian RG; Ellison DW; Jacques TS; Honavar M; Aronica E; Thom M; Sahm F; von Deimling A; Jones DTW; Blumcke I; Capper D
    Acta Neuropathol; 2020 Jan; 139(1):193-209. PubMed ID: 31563982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
    Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.
    Ramkissoon LA; Horowitz PM; Craig JM; Ramkissoon SH; Rich BE; Schumacher SE; McKenna A; Lawrence MS; Bergthold G; Brastianos PK; Tabak B; Ducar MD; Van Hummelen P; MacConaill LE; Pouissant-Young T; Cho YJ; Taha H; Mahmoud M; Bowers DC; Margraf L; Tabori U; Hawkins C; Packer RJ; Hill DA; Pomeroy SL; Eberhart CG; Dunn IF; Goumnerova L; Getz G; Chan JA; Santagata S; Hahn WC; Stiles CD; Ligon AH; Kieran MW; Beroukhim R; Ligon KL
    Proc Natl Acad Sci U S A; 2013 May; 110(20):8188-93. PubMed ID: 23633565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas.
    Ryall S; Zapotocky M; Fukuoka K; Nobre L; Guerreiro Stucklin A; Bennett J; Siddaway R; Li C; Pajovic S; Arnoldo A; Kowalski PE; Johnson M; Sheth J; Lassaletta A; Tatevossian RG; Orisme W; Qaddoumi I; Surrey LF; Li MM; Waanders AJ; Gilheeney S; Rosenblum M; Bale T; Tsang DS; Laperriere N; Kulkarni A; Ibrahim GM; Drake J; Dirks P; Taylor MD; Rutka JT; Laughlin S; Shroff M; Shago M; Hazrati LN; D'Arcy C; Ramaswamy V; Bartels U; Huang A; Bouffet E; Karajannis MA; Santi M; Ellison DW; Tabori U; Hawkins C
    Cancer Cell; 2020 Apr; 37(4):569-583.e5. PubMed ID: 32289278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review of paediatric low-grade diffuse glioma: pathology, molecular genetics and treatment.
    Ryall S; Tabori U; Hawkins C
    Brain Tumor Pathol; 2017 Apr; 34(2):51-61. PubMed ID: 28342104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.
    Ho CY; Mobley BC; Gordish-Dressman H; VandenBussche CJ; Mason GE; Bornhorst M; Esbenshade AJ; Tehrani M; Orr BA; LaFrance DR; Devaney JM; Meltzer BW; Hofherr SE; Burger PC; Packer RJ; Rodriguez FJ
    Acta Neuropathol; 2015 Oct; 130(4):575-85. PubMed ID: 26264609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.
    Lassaletta A; Zapotocky M; Mistry M; Ramaswamy V; Honnorat M; Krishnatry R; Guerreiro Stucklin A; Zhukova N; Arnoldo A; Ryall S; Ling C; McKeown T; Loukides J; Cruz O; de Torres C; Ho CY; Packer RJ; Tatevossian R; Qaddoumi I; Harreld JH; Dalton JD; Mulcahy-Levy J; Foreman N; Karajannis MA; Wang S; Snuderl M; Nageswara Rao A; Giannini C; Kieran M; Ligon KL; Garre ML; Nozza P; Mascelli S; Raso A; Mueller S; Nicolaides T; Silva K; Perbet R; Vasiljevic A; Faure Conter C; Frappaz D; Leary S; Crane C; Chan A; Ng HK; Shi ZF; Mao Y; Finch E; Eisenstat D; Wilson B; Carret AS; Hauser P; Sumerauer D; Krskova L; Larouche V; Fleming A; Zelcer S; Jabado N; Rutka JT; Dirks P; Taylor MD; Chen S; Bartels U; Huang A; Ellison DW; Bouffet E; Hawkins C; Tabori U
    J Clin Oncol; 2017 Sep; 35(25):2934-2941. PubMed ID: 28727518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas.
    Zhang J; Wu G; Miller CP; Tatevossian RG; Dalton JD; Tang B; Orisme W; Punchihewa C; Parker M; Qaddoumi I; Boop FA; Lu C; Kandoth C; Ding L; Lee R; Huether R; Chen X; Hedlund E; Nagahawatte P; Rusch M; Boggs K; Cheng J; Becksfort J; Ma J; Song G; Li Y; Wei L; Wang J; Shurtleff S; Easton J; Zhao D; Fulton RS; Fulton LL; Dooling DJ; Vadodaria B; Mulder HL; Tang C; Ochoa K; Mullighan CG; Gajjar A; Kriwacki R; Sheer D; Gilbertson RJ; Mardis ER; Wilson RK; Downing JR; Baker SJ; Ellison DW;
    Nat Genet; 2013 Jun; 45(6):602-12. PubMed ID: 23583981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric low-grade glioma in the era of molecular diagnostics.
    Ryall S; Tabori U; Hawkins C
    Acta Neuropathol Commun; 2020 Mar; 8(1):30. PubMed ID: 32164789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYB/MYBL1::QKI fusion-positive diffuse glioma.
    Suh YY; Lee K; Shim YM; Phi JH; Park CK; Kim SK; Choi SH; Yun H; Park SH
    J Neuropathol Exp Neurol; 2023 Feb; 82(3):250-260. PubMed ID: 36592415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrative molecular and genomic analysis of pediatric hemispheric low-grade gliomas: an update.
    Lassaletta A; Zapotocky M; Bouffet E; Hawkins C; Tabori U
    Childs Nerv Syst; 2016 Oct; 32(10):1789-97. PubMed ID: 27659822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics and therapeutic targets of pediatric low-grade gliomas.
    Tateishi K; Nakamura T; Yamamoto T
    Brain Tumor Pathol; 2019 Apr; 36(2):74-83. PubMed ID: 30929113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric low-grade gliomas and the need for new options for therapy: Why and how?
    Qaddoumi I; Sultan I; Broniscer A
    Cancer Biol Ther; 2009 Jan; 8(1):4-10. PubMed ID: 19164945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults.
    Rodriguez FJ; Vizcaino MA; Lin MT
    J Mol Diagn; 2016 Sep; 18(5):620-634. PubMed ID: 27444975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric-type diffuse low-grade glioma with
    Kalelioglu T; Rama B; Cho BB; Lopes BM; Patel SH
    Neuroradiol J; 2023 Apr; 36(2):232-235. PubMed ID: 36074655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric low-grade gliomas: how modern biology reshapes the clinical field.
    Bergthold G; Bandopadhayay P; Bi WL; Ramkissoon L; Stiles C; Segal RA; Beroukhim R; Ligon KL; Grill J; Kieran MW
    Biochim Biophys Acta; 2014 Apr; 1845(2):294-307. PubMed ID: 24589977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.